Skip to main content

Table 1 Demographic and clinical characteristics of enrolled systemic sclerosis patients

From: Correlation of retinal and choroidal microvascular impairment in systemic sclerosis

Parameter Distribution or median (min–max)
Gender (female/male) 11/4
Age (years) 63 (49–77)
Disease duration (months) 60 (13–228)
Classification (limited/diffuse cutaneous SSc) 12/3
Vasodilatative comedication (Calcium channel blockers; Phosphodiesterase type 5 inhibitor inhibitors; Endothelin receptor antagonist; Prostacyclin analogue) 13/15
Immunosuppressive comedication (Methotrexate; Mycophenolate mofetil; Azathioprine; Hydroxychloroquine) 12/15
Modified Rodnan Skin Score (0–51) 6 (2–24)
Raynaud + 15/15
History of digital ulcers 12/15
Capillaroscopic skin ulcer risk Index 0.6 (0–41.7)
Arthritis 8/15
Pulmonary fibrosis 9/15
Erythrocyte sedimentation rate (mm) 18 (12–60)
C-Reactive protein (mg/l) 5.1 (0.9–16.6)
ANA + 15/15
Anti-RNA polymerase III + 3/15
Anti-centromere + 7/15
Anti-Scl70 + 6/15